tibolone has been researched along with Depression in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altwerger, G; Black, J; Feinberg, J; Menderes, G; Ratner, E; Whicker, M | 1 |
| Bleeker, C; Gavrilidis, E; Gurvich, C; Hudaib, AR; Kulkarni, J; Thew, C; Thomas, N; Worsley, R | 1 |
| Gavrilidis, E; Khan, N; Kulkarni, J | 1 |
| Burrows, E; Cai, X; Gu, Y; Huang, H; Qu, F; Zhang, R; Zhou, J | 1 |
| Aktaş, A; Kanik, A; Pata, O; Tot, S; Yazici, A; Yazici, K | 1 |
| Camli, L; Gülseren, L; Gülseren, S; Kalafat, D; Mandaci, H | 1 |
| Ayas, B; Baksu, A; Baksu, B; Citak, S; Goker, N; Kalan, A | 1 |
| Basson, R; Brotto, LA; Laan, E; Redmond, G; Utian, WH | 1 |
| Alder, EM; Brown, J; Cawood, EH; Gebbie, AE; Ross, LA | 1 |
| Luzuy, F; Martin-Du Pan, RC | 1 |
2 review(s) available for tibolone and Depression
| Article | Year |
|---|---|
Management of sexuality, intimacy, and menopause symptoms in patients with ovarian cancer.
Topics: Administration, Topical; Anabolic Agents; Body Image; Cognitive Behavioral Therapy; Depression; Estrogen Antagonists; Estrogens; Fatigue; Female; Hormone Replacement Therapy; Humans; Lubricants; Menopause, Premature; Norpregnenes; Ovarian Neoplasms; Pelvic Floor Disorders; Physical Therapy Modalities; Phytotherapy; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sexuality; Tamoxifen; Testosterone | 2017 |
[What's new in hormone replacement therapy for postmenopausal women? I. Advantages of hormone replacement therapy (HRT)].
Topics: Aged; Alzheimer Disease; Cardiovascular Diseases; Cholesterol, HDL; Depression; Dyspareunia; Estrogen Replacement Therapy; Female; Humans; Male; Megestrol; Middle Aged; Norpregnenes; Osteoporosis; Postmenopause; Progesterone Congeners | 2000 |
5 trial(s) available for tibolone and Depression
| Article | Year |
|---|---|
Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone.
Topics: Administration, Oral; Adult; Affect; Antidepressive Agents; Depression; Double-Blind Method; Estrogen Receptor Modulators; Female; Humans; Menopause; Middle Aged; Norpregnenes; Treatment Outcome | 2018 |
Chinese medicinal herbs in relieving perimenopausal depression: a randomized, controlled trial.
Topics: Adult; China; Depression; Drugs, Chinese Herbal; Estradiol; Estrogen Receptor Modulators; Female; Follicle Stimulating Hormone; Humans; Magnoliopsida; Middle Aged; Norpregnenes; Organotherapy; Perimenopause; Phytotherapy | 2009 |
[The effects of hormone replacement therapy in menopause on symptoms of anxiety and depression].
Topics: Anxiety; Depression; Estradiol; Estrogen Replacement Therapy; Female; Humans; Manifest Anxiety Scale; Menopause; Middle Aged; Norpregnenes; Treatment Outcome | 2003 |
Efficacy of tibolone and transdermal estrogen therapy on psychological symptoms in women following surgical menopause.
Topics: Administration, Cutaneous; Anxiety; Depression; Double-Blind Method; Estradiol Congeners; Estrogen Receptor Modulators; Female; Humans; Menopause; Norpregnenes; Prospective Studies | 2005 |
Psychological effects of hormone replacement therapy: a comparison of tibolone and a sequential estrogen therapy.
Topics: Aged; Anabolic Agents; Anxiety; Depression; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Linear Models; Middle Aged; Norgestrel; Norpregnenes; Premenopause; Progesterone Congeners; Prospective Studies | 1999 |
3 other study(ies) available for tibolone and Depression
| Article | Year |
|---|---|
Tibolone treatment for perimenopausal depression: Three cases.
Topics: Depression; Estrogen Receptor Modulators; Female; Humans; Middle Aged; Norpregnenes; Perimenopause | 2016 |
Effects of tibolone on the quality of life, anxiety-depression levels and cognitive functions in natural menopause: an observational follow-up study.
Topics: Anxiety; Cognition; Depression; Estrogen Receptor Modulators; Female; Health Status Indicators; Humans; Menopause; Middle Aged; Norpregnenes; Quality of Life | 2005 |
Assessment and management of women's sexual dysfunctions: problematic desire and arousal.
Topics: Adult; Androgens; Bupropion; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Uptake Inhibitors; Estrogen Receptor Modulators; Estrogens; Female; Humans; Libido; Norpregnenes; Prevalence; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Treatment Outcome | 2005 |